Genetic engineering of Lactococcus lactis to produce an amylase inhibitor for development of an anti-diabetes biodrug. [electronic resource]
- The new microbiologica Jan 2012
- 35-42 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't